Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
701 to 720 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Tumor-derived extracellular vesicles modulate innate immune responses to affect tumor progression. | Front Immunol | 2022 | 36405712 | PubTator, text mining | PubMed |
| Genomic landscape of the immunogenicity regulation in skin melanomas with diverse tumor mutation burden. | Front Immunol | 2022 | 36389735 | PubTator, text mining | PubMed |
| The Cuproptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Tumour Immune Analysis in Osteosarcoma. | Comput Math Methods Med | 2022 | 36388161 | PubTator, text mining | PubMed |
| Co-transducing B7H3 CAR-NK cells with the DNR preserves their cytolytic function against GBM in the presence of exogenous TGF-β. | Mol Ther Methods Clin Dev | 2022 | 36381305 | PubTator, text mining | PubMed |
| Therapeutic Implementation of Oncolytic Viruses for Cancer Immunotherapy: Review of Challenges and Current Clinical Trials. | J Biomed Sci Res | 2022 | 36381110 | PubTator, text mining | PubMed |
| Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma. | Cancer Cell | 2022 | 36379208 | PubTator, text mining | PubMed |
| Single-cell sequencing unveils key contributions of immune cell populations in cancer-associated adipose wasting. | Cell Discov | 2022 | 36376273 | PubTator, text mining | PubMed |
| Limited T-Cell-Stimulating Effect of Cytochalasin-B-Induced Membrane Vesicles Isolated from Artificial Antigen-Presenting Cells. | Vaccines (Basel) | 2022 | 36366388 | PubTator, text mining | PubMed |
| FcγRs and Their Relevance for the Activity of Anti-CD40 Antibodies. | Int J Mol Sci | 2022 | 36361658 | PubTator, text mining | PubMed |
| Defining the Role of Monocytes in Sjögren's Syndrome. | Int J Mol Sci | 2022 | 36361554 | PubTator, text mining | PubMed |
| Cuprotosis Programmed-Cell-Death-Related lncRNA Signature Predicts Prognosis and Immune Landscape in PAAD Patients. | Cells | 2022 | 36359832 | PubTator, text mining | PubMed |
| The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation. | Cancers (Basel) | 2022 | 36358792 | PubTator, text mining | PubMed |
| Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma. | Pharmaceuticals (Basel) | 2022 | 36355508 | PubTator, text mining | PubMed |
| Novel IKZF3 transcriptomic signature correlates with positive outcomes of skin cutaneous melanoma: A pan-cancer analysis. | Front Genet | 2022 | 36353107 | PubTator, text mining | PubMed |
| Natural killer cells in clinical development as non-engineered, engineered, and combination therapies. | J Hematol Oncol | 2022 | 36348457 | PubTator, text mining | PubMed |
| HIV specific CD8+ TRM-like cells in tonsils express exhaustive signatures in the absence of natural HIV control. | Front Immunol | 2022 | 36330531 | PubTator, text mining | PubMed |
| Immunotherapy approaches for hematological cancers. | iScience | 2022 | 36325064 | PubTator, text mining | PubMed |
| Chimeric antigen receptor-engineered NK cells: new weapons of cancer immunotherapy with great potential. | Exp Hematol Oncol | 2022 | 36324149 | PubTator, text mining | PubMed |
| A novel cuproptosis-related immune checkpoint gene signature identification and experimental validation in hepatocellular carcinoma. | Sci Rep | 2022 | 36323801 | PubTator, text mining | PubMed |
| Advances in immunotherapy for glioblastoma multiforme. | Front Immunol | 2022 | 36311781 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=36